Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review

BACKGROUND: Interleukin (IL)-1 inhibitors represent the main treatment in patients with colchicine-resistant/intolerant familial Mediterranean fever (crFMF), mevalonate kinase deficiency (MKD), and tumor necrosis factor receptor-associated periodic syndrome (TRAPS). However, the reasons for the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinit, Caroline, Georgin-Lavialle, Sophie, Theodoropoulou, Aikaterini, Barbier, Catherine, Belot, Alexandre, Mejbri, Manel, Pillet, Pascal, Pachlopnik, Jana, Poignant, Sylvaine, Rebelle, Charlotte, Woerner, Andreas, Koné-Paut, Isabelle, Hentgen, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632237/
https://www.ncbi.nlm.nih.gov/pubmed/34858402
http://dx.doi.org/10.3389/fimmu.2021.744780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632237/
https://www.ncbi.nlm.nih.gov/pubmed/34858402
http://dx.doi.org/10.3389/fimmu.2021.744780

Ejemplares similares